Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case report

Lung cancer is the leading cause of cancer-associated mortality worldwide, and the mainstay of treatment remains to be personalised therapy. Tyrosine kinase inhibitors of the epidermal growth factor receptor (EGFR-TKIs) have been reported to exert a significant impact in the treatment of non-small c...

Descripción completa

Detalles Bibliográficos
Autores principales: ALÌ, GRETA, CHELLA, ANTONIO, LUPI, CRISTIANA, PROIETTI, AGNESE, NICCOLI, CRISTINA, BOLDRINI, LAURA, DAVINI, FEDERICO, MUSSI, ALFREDO, FONTANINI, GABRIELLA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356289/
https://www.ncbi.nlm.nih.gov/pubmed/25788996
http://dx.doi.org/10.3892/ol.2015.2897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356289/
https://www.ncbi.nlm.nih.gov/pubmed/25788996
http://dx.doi.org/10.3892/ol.2015.2897

Ejemplares similares